Glycopyrrolate (Lonhala magnair) for treatment of chronic obstructive pulmonary disease

Montgomery Douglas

Glycopyrrolate (Lonhala magnair) for treatment of chronic obstructive pulmonary disease

Montgomery Douglas

Family Practice

SUNY Downstate Health Sciences University

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Abstract

Glycopyrrolate nebulizer solution (Lonhala Magnair) is labeled for long-term maintenance therapy of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It is available with a portable nebulizer for self-administration by patients.

Original language	English
Pages (from-to)	647-648
Number of pages	2
Journal	American Family Physician
Volume	99
Issue number	10
State	Published - 2019

Cite this

@article{acf8157cd731459d9eb83de63c156601,

title = "Glycopyrrolate (Lonhala magnair) for treatment of chronic obstructive pulmonary disease",

abstract = "Glycopyrrolate nebulizer solution (Lonhala Magnair) is labeled for long-term maintenance therapy of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It is available with a portable nebulizer for self-administration by patients.",

author = "Montgomery Douglas",

note = "Publisher Copyright: {\textcopyright} 2019 American Academy of Family Physicians.",

year = "2019",

language = "English",

volume = "99",

pages = "647--648",

journal = "American Family Physician",

issn = "0002-838X",

publisher = "American Academy of Family Physicians",

number = "10",

}

TY - JOUR

T1 - Glycopyrrolate (Lonhala magnair) for treatment of chronic obstructive pulmonary disease

AU - Douglas, Montgomery

PY - 2019

Y1 - 2019

N2 - Glycopyrrolate nebulizer solution (Lonhala Magnair) is labeled for long-term maintenance therapy of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It is available with a portable nebulizer for self-administration by patients.

AB - Glycopyrrolate nebulizer solution (Lonhala Magnair) is labeled for long-term maintenance therapy of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It is available with a portable nebulizer for self-administration by patients.

UR - https://www.scopus.com/pages/publications/85066843630

M3 - Comment/debate

C2 - 31083881

SN - 0002-838X

VL - 99

SP - 647

EP - 648

JO - American Family Physician

JF - American Family Physician

IS - 10

ER -

Glycopyrrolate (Lonhala magnair) for treatment of chronic obstructive pulmonary disease

Abstract

Other files and links

Fingerprint

Cite this